ARTICLE | Company News
Myriad Genetics, Bioscientia Ltd. sales and marketing update
July 2, 2001 7:00 AM UTC
Bioscientia will provide MYGN's BRACAnalysis predictive medicine tests for breast and ovarian cancer in Germany, Switzerland and Austria. ...